PTC Therapeutics (NASDAQ: PTCT) Just Broke Out to a 52-Week High – Could Soar Another 38%
Plus, our recommended trade with ABBV touched our first price target to deliver a potential 12% return from entry in under two weeks. The post PTC Therapeutics (NASDAQ: PTCT) Just…
Written byGreg PatrickSource: Trades Of The Day
Plus, our recommended trade with ABBV touched our first price target to deliver a potential 12% return from entry in under two weeks.
The post PTC Therapeutics (NASDAQ: PTCT) Just Broke Out to a 52-Week High – Could Soar Another 38% appeared first on Trades Of The Day.